| Literature DB >> 27515794 |
Kathleen Martin1, Jugpreet Singh2, John H Hill3, Steven A Whitham3, Steven B Cannon4,5.
Abstract
BACKGROUND: Bean common mosaic virus (BCMV) is widespread, with Phaseolus species as the primary host plants. Numerous BCMV strains have been identified on the basis of a panel of bean varieties that distinguish the pathogenicity types with respect to the viral strains. The molecular responses in Phaseolus to BCMV infection have not yet been well characterized.Entities:
Keywords: Bean common mosaic virus; Gene expression; Gene regulation; Host-virus interaction; Phaseolus vulgaris; Regulatory changes
Mesh:
Substances:
Year: 2016 PMID: 27515794 PMCID: PMC4982238 DOI: 10.1186/s12864-016-2976-8
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Comparative analysis of NL1-I and BCMV-S2 genomes. (a) The genome organization of bean common mosaic virus. (b) The amino acid differences between NL1-I and BCMV-S2 strains. The virus genomes from two studied virus strains were separately assembled using Trinity software [45]. The sequence span for each virus genome component is provided below the component name. The position of polymorphic sites between two virus strains is presented with the changed amino acids in brackets. The left amino acid belongs to NL1-I and right amino acid represents BCMV-S2 strain. The amino acid changes presented in grey color here, either change the conformation of the protein, binding to other proteins or function of the protein
Read statistics for healthy and BCMV inoculated treatments at 4 and 8 days after infection
| Day4 Healthy | Day4 NL1-I | Day4 BCMV-S2 | Day8 Healthy | Day8 NL1-I | Day8 BCMV-S2 | |
|---|---|---|---|---|---|---|
| Total Number of Reads | 100384228 | 85580983 | 95822434 | 100826142 | 101771895 | 97866045 |
| Average Number of Reads | 33461409 | 28526994 | 31940811 | 33608714 | 33923965 | 32622015 |
| Cleaned Reads | 33424094 | 28496111 | 31900317 | 33566283 | 33881828 | 32580889 |
| Mapped | 32016716 (95.8 %) | 27359710 (96.0 %) | 30558211 (95.8 %) | 32359045 (96.4 %) | 31295370 (92.4 %) | 28489996 (87.4 %) |
| Unique Alignment | 28953972 (86.6 %) | 25106389 (88.1 %) | 27610543 (86.5 %) | 29033850 (86.5 %) | 28563040 (84.3 %) | 25955587 (80.0 %) |
| Multiple Alignment | 3062744 (9.6 %) | 2253321 (8.2 %) | 2947668 (9.6 %) | 3325195 (10.3 %) | 2732330 (8.7 %) | 2534409 (8.9 %) |
| Reads Unmapped | 1407378 (4.2 %) | 1136400 (4.0 %) | 1342105 (4.2 %) | 1207238 (3.6 %) | 2586458 (7.6 %) | 4090893 (12.5 %) |
| Intragenic Mapping | 29974232 (93.6 %) | 25976900 (94.9 %) | 28844743 (94.4 %) | 31105962 (96.1 %) | 29702292 (94.9 %) | 26984179 (94.7 %) |
| Exon Mapping | 28665015 (89.5 %) | 24837853 (90.7 %) | 27654993 (90.5 %) | 29549785 (91.3 %) | 28357718 (90.6 %) | 25632321 (90.0 %) |
| Intron Mapping | 1309218 (4.1 %) | 1139048 (4.2 %) | 1189751 (3.9 %) | 1556179 (4.8 %) | 1344572 (4.3 %) | 1351857 (4.7 %) |
| Intergenic Mapping | 2019225 (6.3 %) | 1369481 (5.0 %) | 1692646 (5.5 %) | 1244967 (3.8 %) | 1582672 (5.0 %) | 1496416 (5.2 %) |
| Genes Detected | 21377 | 21179 | 21365 | 21432 | 21667 | 21400 |
Total number of reads represent the total count across three biological replicates, while average number of reads represent the mean value from three biological replicates. The genes were considered as expressed with minimum three reads aligned to a gene model
Fig. 2Various alternate splicing (AS) events and their distribution patterns in different virus treatments. (a) Representation of various AS events frequently observed in P. vulgaris. (b) Number of genes and corresponding transcripts with significant (padj < 0.05) differential splicing (AS) patterns for each virus treatments. (c) Different in number of different AS forms (significantly spliced transcripts) in healthy and NL1-I infected samples. (d) Different in number of different AS forms (significantly spliced transcripts) in healthy and BCMV-S2 infected samples. The transcripts were built using cufflinks2 and significant differential splicing events were detected using cuffdiff2 [36, 37]. Low abundance transcripts (FPKM < 0.3) were eliminated to avoid misassembly issues due to low read count. Alternate Splicing Transcriptional Landscape Visualization Tool, ASTALAVISTA [38], was used to characterize different AS events
Fig. 3Differentially expressed (DE) transcripts (padj < 0.05) upon NL1-I and BCMV-S2 treatments. The transcripts were called as significant using adjusted p values less than 0.05 with false discovery rate (FDR) and log2 fold values more than 1 or less than −1. The extent and distribution of transcript expression differences were visualized using volcano plots for (a) NL1-I treatment, (b) BCMV-S2 treatments. The x-axis represent –log10 of adjusted p-values (FDR; [43], and y-axis represent log2 fold change values between control and treatment comparison. The numbers of significant DE genes were shown using bar plot (c), where orange color represent significantly downregulated genes and blue color represent significantly upregulated genes upon different virus treatments
Fig. 4The number of DE genes uniquely expressed or shared between NL1-I and BCMV-S2 virus treatments. The induced (a) and repressed (b) genes were plotted separately for each virus treatments
List of top 30 upregulated genes (p < 0.05) on NL1-I and BCMV-S2 virus treatments, respectively
| NL1-I | Log2 fold change | Annotation | BCMV-S2 | Log2 fold change | Annotation |
|---|---|---|---|---|---|
|
| 6.27 | WRKY DNA -binding domain | Phvul.001G040600 | 3.97 | Protein kinase domain |
|
| 5.93 | Leucine rich repeat N-terminal domain | Phvul.001G042100 | 4.27 | WRKY DNA -binding domain |
| Phvul.001G070000 | 5.97 | Protein tyrosine kinase |
| 4.34 | WRKY DNA -binding domain |
|
| 6.82 | Glycosyl hydrolases family 17 |
| 4.04 | Leucine rich repeat N-terminal domain |
|
| 6.70 | CALCIUM-BINDING EF HAND FAMILY PROTEIN |
| 4.50 | Glycosyl hydrolases family 17 |
| Phvul.002G180800a | 6.47 | Calcium-binding EF-hand family (0.003) | Phvul.001G192000 | 3.64 | No apical meristem (NAM) protein |
|
| 6.85 | Calcium-binding EF-hand family (0.002) | Phvul.002G075200 | 3.62 | GLUCOSYL/GLUCURONOSYL TRANSFERASES |
| Phvul.002G189900 | 6.02 | VQ motif |
| 3.96 | CALCIUM-BINDING EF HAND FAMILY PROTEIN |
|
| 6.08 | Glucose-6-phosphate/phosphate membrane antiporter |
| 3.76 | Calcium-binding EF-hand family (0.07) |
|
| 6.07 | Pathogenesis-related protein Bet v I family |
| 3.79 | Glucose-6-phosphate/phosphate membrane antiporter |
| Phvul.003G022400 | 6.25 | COPPER TRANSPORT PROTEIN ATOX1-RELATED |
| 4.18 | response to biotic stimulus Pathogenesis-related protein Bet v I family |
|
| 5.91 | Peroxidase activity, response to oxidative stress | Phvul.003G098500 | 3.69 | Protein of unknown function (DUF679) |
| Phvul.003G247500 | 6.17 | LEUCINE-RICH REPEAT-CONTAINING PROTEIN |
| 5.57 | Peroxidase activity, response to oxidative stress |
| Phvul.003G292900 | 5.98 | PLAC8 family | Phvul.004G101500 | 3.65 | Hydrolase activity, hydrolyzing O-glycosyl compounds |
|
| 6.52 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE | Phvul.004G142700 | 3.95 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
|
| 6.59 | NA |
| 3.92 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
| Phvul.005G054100 | 6.11 | Glutathione S-transferase | Phvul.005G026600a | 4.17 | Plant protein 1589 of unknown function (0.03) |
| Phvul.005G054200 | 6.59 | Glutathione S-transferase |
| 5.42 | NA |
|
| 6.41 | WD domain, G-beta repeat | Phvul.005G038300 | 4.17 | NA |
|
| 6.24 | Peroxidase activity, response to oxidative stress | Phvul.005G133400 | 4.03 | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) |
| Phvul.006G172000 | 6.39 | NA | Phvul.005G164500 | 3.74 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
|
| 8.27 | Pathogenesis-related protein |
| 3.69 | WD domain, G-beta repeat |
|
| 8.05 | Pathogenesis-related protein | Phvul.006G038100 | 3.62 | NA |
| Phvul.007G040900 | 5.99 | Peptidase |
| 4.46 | Peroxidase activity, response to oxidative stress |
| Phvul.008G011500 | 7.15 | Oxidation-reduction process, C1-like domain | Phvul.006G130000 | 5.72 | Peroxidase activity, response to oxidative stress |
| Phvul.008G044400 | 5.90 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
| 4.61 | Pathogenesis-related protein |
| Phvul.008G080000 | 5.88 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
| 5.80 | Pathogenesis-related protein |
|
| 6.90 | Tubby C 2 | Phvul.007G050500 | 4.17 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
|
| 7.31 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE | Phvul.007G211600 | 4.52 | NA |
|
| 6.90 | NA | Phvul.008G088400 | 3.88 | Tubby C 2 |
The bold gene names are common between the two treatments. Gene annotations were retrieved for common bean genome in Phytozome. The unannotated genes were functionally classified using TAIR (indicated by a, the e-value of TAIR match is indicated in the brackets). "NA" represents no functional characterization of gene is available
List of top 30 downregulated genes (p < 0.05) on NL1-I and BCMV-S2 virus treatments, respectively
| NL1-I | Log2 fold change | Annotation | BCMV-S2 | Log2 fold change | Annotation |
|---|---|---|---|---|---|
| Phvul.001G050500 | −2.68 | Adenine Phosphoribosyltransferase | Phvul.001G021700a | −2.38 | Protein kinase superfamily (0.010) |
|
| −3.65 | Homocitrate synthase-related |
| −4.08 | HOMOCITRATE SYNTHASE-RELATED |
|
| −3.31 | dsRNA-binding protein 3 (DRB3) (0.007) | Phvul.001G091700a | −3.24 | ARABIDOPSIS HEAVY METAL ATPASE 8 (0.029) |
|
| −2.75 | ABC-2 type transporter |
| −2.68 | dsRNA-binding protein 3 (DRB3) (0.007) |
| Phvul.001G206500a | −2.79 | Hexokinase 3 (0.006) | Phvul.001G151900 | −2.87 | Terpene synthase family, metal binding domain |
| Phvul.001G239100a | −3.00 | Encodes a microRNA that targets several TIR1/AFB family members (0.003) | Phvul.001G165800 | −3.38 | ABC transporter |
| Phvul.002G153600 | −2.80 | Hydroxymethylglutaryl-CoA synthase |
| −3.05 | ABC-2 type transporter |
| Phvul.002G193300 | −3.00 | Oxidoreductase, 20G-Fe(II) oxygenase family protein | Phvul.001G166200 | −2.42 | ABC-2 type transporter |
|
| −3.24 | Squalene Monooxygenase | Phvul.001G206700 | −2.53 | ABC transporter |
|
| −3.15 | Transposable element gene (0.092) | Phvul.001G251300 | −2.34 | TREHALOSE-6-PHOSPHATE SYNTHASE |
| Phvul.002G268800 | −3.79 | EamA-like transporter family | Phvul.001G263900 | −2.36 | Protein of unknown function (DUF1264) |
|
| −3.35 | RING/U-box superfamily protein (0.055) | Phvul.002G059500 | −2.33 | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
|
| −3.53 | Mediator complex subunit Med23 (0.075) | Phvul.002G150200 | −2.74 | Drug transmembrane transporter activity |
| Phvul.003G159200 | −2.91 | Plasma membrane H + −transporting ATPase |
| −2.48 | SQUALENE MONOOXYGENASE |
| Phvul.003G192800 | −2.81 | H+/oligopeptide symporter | Phvul.002G227500a | −2.69 | Encodessl dehydroquinate-shikimate dehydrogenase enzyme (2e-08) |
| Phvul.003G218900 | −3.27 | Protease inhibitor/seed storage/LTP family |
| −2.32 | Transposable element gene (0.092) |
| Phvul.003G248200 | −2.98 | Alpha/Beta Hydrolase Fold-Containing Protein | Phvul.002G294200 | −2.80 | AAA-FAMILY ATPASE |
|
| −3.03 | Glucose dehydrogenase/choline dehydrogenase/mandelonitrile Lyase |
| −2.55 | RING/U-box superfamily protein (0.055) |
| Phvul.004G142000 | −3.17 | Synaptic vesicle and related transporters |
| −3.13 | Mediator complex subunit Med23 (0.075) |
|
| −3.24 | Cellulose synthase | Phvul.003G060100 | −2.92 | Dehydrogenases with different specificities |
| Phvul.005G005000 | −2.83 | ATP binding | Phvul.003G082300 | −2.36 | OXIDOREDUCTASE, 2OG-FE(II) OXYGENASE FAMILY PROTEIN |
|
| −2.69 | UDP-glucoronosyl and UDP-glucosyl transferase |
| −2.59 | Glucose dehydrogenase/choline dehydrogenase/mandelonitrile lyase |
|
| −3.68 | Dirigent-like protein |
| −2.49 | Cellulose synthase |
|
| −3.28 | Dirigent-like protein |
| −2.47 | UDP-glucoronosyl and UDP-glucosyl transferase |
| Phvul.005G069400 | −3.09 | NA |
| −3.09 | Dirigent-like protein |
| Phvul.005G145700 | −2.72 | DVL family |
| −2.73 | Dirigent-like protein |
|
| −3.25 | GTP-binding protein |
| −2.94 | GTP-binding protein |
| Phvul.005G166200 | −4.20 | Phosphorelay signal transduction system | Phvul.006G195500 | −2.54 | Helix-loop-helix DNA-binding domain, transcription regulator activity |
| Phvul.005G170300 | −3.09 | Aquaporin (major intrinsic protein family) |
| −3.09 | ABC transporter |
| Phvul.006G034000 | −2.71 | NAD dependent epimerase/dehydratase family | Phvul.007G275800 | −2.38 | Hemopexin |
The gene names in bold are common between the two treatments. Gene annotations were retrieved for common bean genome in Phytozome. The unannotated genes were functionally classified using TAIR (indicated by a, the e-value of TAIR match is indicated in the brackets). "NA" represents no functional characterization of gene is available
Fig. 5Significantly enriched GO slim categories after NL1-I virus treatment. Significant DE genes (padj < 0.05, log2 fold −1,1) identified after NL1-I treatment were used to perform GO enrichment analysis. The number of genes within each category is represented on x-axis. The significant overrepresented GO classes (false discovery rate corrected p-value < 0.05) were identified using agriGO analysis tool [41] Phaseolus vulgaris version1 genome annotations
Fig. 6Significantly enriched GO slim categories after BCMV-S2 virus treatment. Significant DE genes (padj < 0.05, log2 fold −1,1) identified after BCMV-S2 treatment were used to perform GO enrichment analysis. The number of genes within each category is represented on x-axis. The significant overrepresented GO classes (false discovery rate corrected p-value < 0.05) were identified using agriGO analysis tool [41] using Phaseolus vulgaris version1 genome annotations
KEGG pathway analysis using DE genes on NL1-I and BCMV-S2 virus treatments
| Treatment | Dataset | Pathway | DE Genes |
|
|---|---|---|---|---|
| NL1-I | Unique | Plant-pathogen interaction | 20 | 0.049 |
| Photosynthesis - antenna proteins | 12 | 0.001 | ||
| Pentose phosphate pathway | 16 | 0.006 | ||
| Protein processing in endoplasmic reticulum | 39 | 0.014 | ||
| N-Glycan biosynthesis | 12 | 0.020 | ||
| Protein export | 12 | 0.028 | ||
| Biosynthesis of secondary metabolites | 149 | 0.040 | ||
| BCMV-S2 | Unique | Nitrogen metabolism | 9 | 0.049 |
| Ribosome | 23 | 0.000 | ||
| Ribosome biogenesis in eukaryotes | 7 | 0.001 | ||
| Diterpenoid biosynthesis | 3 | 0.007 | ||
| NL1-I, BCMV-S2 | Common | Ribosome | 79 | 0.000 |
| Ribosome biogenesis in eukaryotes | 22 | 0.000 | ||
| Plant-pathogen interaction | 20 | 0.006 | ||
| NL1-I | Downregulated |
| 14 | 0.000 |
|
| 9 | 0.001 | ||
| Biosynthesis of secondary metabolites | 119 | 0.001 | ||
|
| 36 | 0.002 | ||
| Metabolic pathways | 207 | 0.003 | ||
| Carbon fixation in photosynthetic organisms | 15 | 0.003 | ||
| Glyoxylate and dicarboxylate metabolism | 13 | 0.006 | ||
| Pentose phosphate pathway | 12 | 0.008 | ||
| BCMV-S2 | Downregulated |
| 4 | 0.011 |
|
| 14 | 0.014 | ||
| Linoleic acid metabolism | 4 | 0.019 | ||
| Valine, leucine and isoleucine biosynthesis | 3 | 0.035 | ||
| Valine, leucine and isoleucine degradation | 4 | 0.050 | ||
|
| 3 | 0.050 | ||
| NL1-I | Upregulated |
| 111 | 0.000 |
| Protein processing in endoplasmic reticulum | 46 | 0.000 | ||
|
| 41 | 0.000 | ||
|
| 22 | 0.000 | ||
|
| 22 | 0.000 | ||
| Phenylalanine metabolism | 25 | 0.002 | ||
| N-Glycan biosynthesis | 12 | 0.003 | ||
| Phenylpropanoid biosynthesis | 33 | 0.004 | ||
| Protein export | 12 | 0.005 | ||
| BCMV-S2 | Upregulated |
| 102 | 0.000 |
|
| 28 | 0.000 | ||
|
| 17 | 0.004 | ||
|
| 11 | 0.004 |
The analysis was performed using KOBAS v2.0 [42] by splitting the DE genes dataset into unique, shared, upregulated and downregulated genes for studied virus treatments. The pathways in bold letters are significant at adjusted p-value < 0.05
Fig. 7Expression modules associated with DE genes 8 days after NL1-I and BCMV-S2 virus infections. Cluster analysis was performed with k-means (n = 20) using Genesis bioinformatics software [56], (http://genome.tugraz.at). Normalized gene expression values were used and averaged across biological replicates for clustering analysis. The x-axis represents the healthy, NL1-I and BCMV-S2 treatments, respectively. The y-axis represents the normalized expressed values obtained from read counts for each models. Enriched gene ontology (GO) terms for various expression modules are indicated
Number of differentially expressed transcription factors (TFs) on NL1-I and BCMV-S2 virus infections
| NL1-I | BCMV-S2 | |
|---|---|---|
| Number of Detected TF Families | 33 | 21 |
| Number of Detected TFs | 246 (5.26 %) | 101 (4.81 %) |
| Upregulated | 138 (2.95 %) | 56 (2.67 %) |
| Downregulated | 108 (2.31 %) | 45 (2.14 %) |
Significant DE genes (padj < 0.05) were used to identify putative TFs for individual virus treatment. Hidden Markov Motifs (HMM) representing 61 different legume transcription factor families [44] were compared against the DE genes and putative TFs were detected using 90 % sequence homology and e-value ≤ 10−10
Most abundant transcription factor (TF) families detected in DE dataset for NL1-I and BCMV-S2 infections
| NL1-I | BCMV-S2 | |||
|---|---|---|---|---|
| Most Abundant | Induced | Repressed | Induced | Repressed |
| (R1)R2R3_Myb | 11 | 10 | 5 | 5 |
| AP2_EREBP | 12 | 2 | 4 | 3 |
| bHLH | 9 | 17 | 7 | 8 |
| C2H2_Zn | 6 | 8 | 1 | 1 |
| Myb_related | 3 | 13 | 1 | 6 |
| NAC | 20 | 2 | 7 | 1 |
| WRKY_Zn | 25 | 6 | 11 | 1 |
The numbers of genes corresponding to each TF family were counted after blast results. Datasets for upregulated and downregulated genes for each virus treatment was used separately